Victorian Comprehensive Cancer Centre

16 July 2016

Minister for Health, Jill Hennessy, today announced details of the organisations that have secured a coveted place in the state-of-the-art VCCC following a worldwide search.

Level 13 will become the Ian Potter Centre for new Cancer Treatments and provide a home for the Peter Mac led Immunotherapy Research Program, the Australian Genome Research Facility, the Cooperative Research Centre for Cancer Therapeutics and the Innovative Clinical Trials Centre.

These organisations will work collaboratively with other research groups and cancer experts at the VCCC to quickly translate the latest breakthroughs in cancer research into clinical practice, delivering even better care and outcomes for patients.

Level 13 will also be home to the new International Cancer Research Centre where partnerships will be forged with other research entities and global studies and trials will be promoted. They will be joined by the National Proton Beam Therapy Centre who will continue its work to establish Australia’s first Proton Beam Therapy Centre.

The Ian Potter Foundation gifted $15 million in support of cancer research as part of the VCCC Project, and the gift spearheaded the VCCC philanthropic fundraising effort.

The Australian Genome Research Facility is a founding member of the Melbourne Genomics Health Alliance, which received $25 million from the Victorian Government in last year’s State Budget.

The landmark VCCC Project is delivering a $1 billion purpose-built facility that will drive future innovations in cancer research, treatment, care and education.

Peter MacCallum Cancer Centre patients and staff last month moved into the VCCC. It will be officially opened on July 17.

The VCCC will host up to 1200 cancer researchers, featuring new state-of-the-art cancer research and clinical facilities for Peter Mac, Melbourne Health, research facilities for the University of Melbourne and education facilities.

First published on